Atara Biotherapeutics logo
Atara Biotherapeutics ATRA
$ 10.26 -3.93%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Atara Biotherapeutics Financial Ratios 2011-2024 | ATRA

Annual Financial Ratios Atara Biotherapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.3 -2.3 -4.3 -4.7 -2.4 -6.9 -10.1 -4.6 -8.1 -4.3 - - -

P/S

8.5 8.2 - - - - - - - - - - -

EPS

-2.6 -2.2 -3.6 -4.2 -5.7 -5.3 -4 -2.8 - - - - -

EV (Enterprise Value)

312 M 676 M 1.56 B 1.38 B 676 M 1.58 B 1.16 B 326 M 449 M 102 M 11.2 M 3.81 M -

EBITDA per Share

-2.56 -2.69 -3.53 -4.07 -5.63 -5.33 -4.04 -2.81 -2.28 -5.65 - - -

EV/EBITDA

-4.5 -3.9 -2.2 -6.5 -9.3 -3.9 -7.5 -3.5 - - -

PEG

0.02 0.42 -0.54 -0.31 0.32 0.22 0.22 0.2 -0.13 0.01 - - -

P/B

-0.7 4.1 5.3 3.1 2.4 4.7 6.8 1.4 1.5 1.2 - - -

P/CF

-0.4 -1.9 -6.7 -8.0 -2.9 -7.3 -11.2 -5.8 -12.4 -7.3 - - -

ROE %

278.27 -180.28 -121.65 -66.32 -100.07 -68.08 -67.18 -31.15 -18.16 -27.14 - - -

ROA %

-166.84 -60.65 -72.66 -52.14 -84.85 -58.88 -54.87 -29.95 -17.61 -26.39 - - -

ROCE %

278.14 -221.50 -121.76 -66.85 -96.56 -67.39 -63.92 -31.95 -18.54 -27.23 - - -

Current Ratio

0.6 1.5 2.5 4.7 7.4 8.0 6.2 26.9 33.4 38.9 - - -

DSO

1582.3 118.3 - - - - - - - - - - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Operating Cycle

1582.3 118.3 - - - - - - - - - - -

Cash Conversion Cycle

1582.3 118.3 - - - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Atara Biotherapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-2.93 -3.1 -0.23 - -16.4 -16.91 -0.72 - -0.82 0.18 -0.87 - -0.9 -0.91 -0.86 - -0.92 -1.14 -1.2 - -1.31 -1.6 -1.44 - -1.29 -1.15 -1.05 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA per Share

-2.83 -2.85 -0.21 - -16.1 -16.8 -0.71 - -0.82 -0.3 -0.86 - -0.88 -0.89 -0.83 - -0.89 -1.12 -1.19 - -1.29 -1.59 -1.44 - -1.3 -1.17 -1.06 - -1.03 -0.95 -0.89 - -0.9 -0.68 -0.6 - -0.44 -0.62 -0.42 - - -3.39 -5.6 - -2.61 - - -5.58 - - - - - - -

ROE %

210.97 324.07 -647.07 -931.77 -976.71 -1158.94 -197.81 -77.05 -104.35 -86.70 -119.15 -72.20 -88.28 -77.07 -68.55 -48.73 -73.46 -82.10 -90.91 -73.07 -90.30 -82.79 -72.25 -44.47 -61.95 -62.21 -62.62 -47.33 -57.33 -49.84 -41.86 -23.97 -27.73 -21.50 -18.80 -11.42 -17.15 -19.12 -18.75 -16.94 6.08 34.83 39.21 133.30 243.57 220.55 110.28 110.28 - - - - - - -

ROA %

-87.78 -109.40 -122.01 -90.58 -113.41 -99.27 -66.18 -40.77 -59.59 -55.58 -78.16 -51.95 -64.59 -58.42 -53.24 -38.31 -59.27 -67.60 -76.10 -61.96 -76.85 -70.78 -62.09 -38.46 -52.74 -52.12 -51.73 -38.65 -48.27 -43.60 -38.16 -23.04 -26.70 -20.73 -18.18 -11.07 -16.65 -18.57 -18.22 -16.47 -21.36 -20.68 -16.43 -4.89 -4.89 - - - - - - - - - -

ROCE %

- - - - -45.23 -90.45 -102.93 -97.03 -124.38 -106.50 -119.36 -72.29 -88.45 -77.26 -68.79 -49.17 -74.13 -82.92 -92.04 -74.28 -91.40 -83.57 -72.55 -44.15 -60.80 -60.33 -60.05 -45.09 -55.29 -48.85 -41.83 -24.58 -28.47 -22.15 -19.28 -11.63 -17.40 -19.28 -18.88 -17.02 6.15 35.08 39.47 132.98 242.80 219.64 109.82 109.82 - - - - - - -

Current Ratio

0.6 0.5 0.6 0.6 0.8 1.0 1.3 1.5 2.0 2.4 2.3 2.5 3.2 3.6 4.1 4.7 4.7 4.7 4.7 6.6 6.6 6.6 6.6 7.4 7.4 7.4 7.4 5.5 5.5 5.5 5.5 25.9 25.9 25.9 25.9 32.9 32.9 32.9 32.9 36.1 36.1 36.1 36.1 29.6 29.6 - - - - - - - - - -

DSO

4.3 60.9 116.7 - 14.3 43.1 1511.6 - 9.1 1.1 10.3 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

4.3 60.9 116.7 - 14.3 43.1 1511.6 - 9.1 1.1 10.3 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

4.3 60.9 116.7 - 14.3 43.1 1511.6 - 9.1 1.1 10.3 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency